Protect vulnerable patients

Limiting choice of dressings available to patients will increase costs in the long term as wounds will take longer to heal and more nurse time will be necessary. It will stifle innovation by discouraging UK companies from investing in dressings that could make a real difference, and will instead lead to job losses and ultimately compound the existing suffering experienced by patients with wounds. This could have a dramatic effect on morbidity rates for vulnerable patients and even lead to deaths in some cases.